Literature DB >> 8741938

Preference for diazepam, but not buspirone, in moderate drinkers.

S M Evans1, R R Griffiths, H de Wit.   

Abstract

The purpose of the present study was to determine the preference for buspirone, an anxiolytic predicted to have minimal abuse potential, in comparison with diazepam in moderate drinkers. Preference for diazepam and buspirone was assessed in 55 moderate drinkers using a seven-session procedure consisting of four sampling sessions followed by three choice sessions. On each sampling session subjects ingested five capsules, one every 30 min. Color-coded capsules contained placebo on two sessions and drug on two sessions. Each drug capsule contained diazepam (4 mg) for 30 subjects and buspirone (5 mg) for 25 subjects. On choice sessions subjects chose whichever of the two color-coded capsules, i.e., drug or placebo, they wished to take. After ingesting one capsule, every 30 min they had the option of ingesting another capsule of the same color and content, for a maximum of seven capsules over the session (maximum of 28 mg diazepam or 35 mg buspirone). In the diazepam group 70% of subjects chose diazepam over placebo on at least two of the three choice sessions, whereas in the buspirone group only 24% of subjects chose buspirone over placebo on at least two sessions. Both diazepam and buspirone increased measures of sedation. Only diazepam increased ratings of liking and impaired performance, whereas only buspirone decreased ratings of feeling Friendly. These results replicate previous findings indicating that diazepam has reinforcing effects in moderate drinkers. Further, these results demonstrate the pharmacological specificity of this effect by showing that buspirone did not function as a reinforcer under these same conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741938     DOI: 10.1007/bf02246172

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

Review 1.  The discovery and development of buspirone: a new approach to the treatment of anxiety.

Authors:  J S New
Journal:  Med Res Rev       Date:  1990 Jul-Sep       Impact factor: 12.944

2.  Preference for diazepam in anxious adults.

Authors:  S G McCracken; H de Wit; E H Uhlenhuth; C E Johanson
Journal:  J Clin Psychopharmacol       Date:  1990-06       Impact factor: 3.153

3.  Objective determination of benzodiazepine use and abuse in alcoholics.

Authors:  U Busto; J Simpkins; E M Sellers; B Sisson; R Segal
Journal:  Br J Addict       Date:  1983-12

Review 4.  Protracted withdrawal syndromes from benzodiazepines.

Authors:  H Ashton
Journal:  J Subst Abuse Treat       Date:  1991

5.  Reinforcing properties of lorazepam in normal volunteers.

Authors:  H de Wit; C E Johanson; E H Uhlenhuth
Journal:  Drug Alcohol Depend       Date:  1984-01       Impact factor: 4.492

Review 6.  Can buspirone induce rebound, dependence or abuse?

Authors:  M Lader
Journal:  Br J Psychiatry Suppl       Date:  1991-09

7.  Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.

Authors:  R R Griffiths; G E Bigelow; I Liebson; J E Kaliszak
Journal:  J Pharmacol Exp Ther       Date:  1980-12       Impact factor: 4.030

8.  Intravenous buspirone self-administration in rhesus monkeys.

Authors:  R L Balster; W L Woolverton
Journal:  J Clin Psychiatry       Date:  1982-12       Impact factor: 4.384

9.  Buspirone and diazepam in anxiety: a controlled study.

Authors:  K Rickels; K Weisman; N Norstad; M Singer; D Stoltz; A Brown; J Danton
Journal:  J Clin Psychiatry       Date:  1982-12       Impact factor: 4.384

10.  Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo.

Authors:  J C Pecknold; M Matas; B G Howarth; C Ross; R Swinson; C Vezeau; W Ungar
Journal:  Can J Psychiatry       Date:  1989-11       Impact factor: 4.356

View more
  12 in total

1.  Characterizing the subjective and psychomotor effects of carisoprodol in healthy volunteers.

Authors:  James P Zacny; Judith A Paice; Dennis W Coalson
Journal:  Pharmacol Biochem Behav       Date:  2011-08-23       Impact factor: 3.533

2.  Effects of caffeine on alcohol reinforcement: beverage choice, self-administration, and subjective ratings.

Authors:  Mary M Sweeney; Steven E Meredith; Daniel P Evatt; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2017-01-20       Impact factor: 4.530

3.  Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers.

Authors:  James P Zacny; Judith A Paice; Dennis W Coalson
Journal:  Drug Alcohol Depend       Date:  2012-02-25       Impact factor: 4.492

4.  Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC.

Authors:  Joshua A Lile; Thomas H Kelly; Lon R Hays
Journal:  Drug Alcohol Depend       Date:  2014-07-29       Impact factor: 4.492

5.  Amphetamine self-administration in light and moderate drinkers.

Authors:  Matthew D Stanley; Mégan M Poole; William W Stoops; Craig R Rush
Journal:  Alcohol Clin Exp Res       Date:  2010-12-16       Impact factor: 3.455

Review 6.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

7.  Psychopharmacological effects of oxycodone in healthy volunteers: roles of alcohol-drinking status and sex.

Authors:  James P Zacny; Melinda Drum
Journal:  Drug Alcohol Depend       Date:  2009-11-30       Impact factor: 4.492

8.  Choice of sevoflurane and its subjective and psychomotor effects in light and moderate drinkers.

Authors:  James P Zacny; Diana J Walker; Melinda Drum; Molly Sells
Journal:  Drug Alcohol Depend       Date:  2008-04-01       Impact factor: 4.492

9.  Amphetamine-induced place preference in humans.

Authors:  Emma Childs; Harriet de Wit
Journal:  Biol Psychiatry       Date:  2008-12-25       Impact factor: 13.382

10.  MDMA: a social drug in a social context.

Authors:  Matthew G Kirkpatrick; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2014-10-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.